Practice bulletin No. 125: Chronic hypertension in pregnancy

Obstetrics and Gynecology

Volumn 119, Issue 2 PART 1, 2012, Pages 396-407

  Hibbard, Judith ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIAZOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; KETANSERIN; LABETALOL; METADRENALIN; METHYLDOPA; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BED REST; BONE MALFORMATION; BRADYCARDIA; CARBOHYDRATE INTOLERANCE; CENTRAL NERVOUS SYSTEM MALFORMATION; CEREBROVASCULAR ACCIDENT; CESAREAN SECTION; CHRONIC DISEASE; CHRONIC HYPERTENSION; CONGENITAL HEART MALFORMATION; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CUSHING DISEASE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG INDUCED HEADACHE; ELECTROLYTE DISTURBANCE; EPIDURAL ANESTHESIA; ESSENTIAL HYPERTENSION; FETUS DEATH; FETUS ECHOGRAPHY; GENERAL ANESTHESIA; GROWTH RETARDATION; HEART VENTRICLE HYPERTROPHY; HELLP SYNDROME; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY MALFORMATION; LABOR COMPLICATION; LASER DOPPLER FLOWMETRY; LIVER FUNCTION TEST; LUNG EDEMA; LUNG HYPOPLASIA; MATERNAL HYPERTENSION; NEWBORN DEATH; NULLIPARA; OBSTETRIC ANESTHESIA; OLIGOHYDRAMNIOS; OLIGURIA; PERINATAL MORTALITY; PHEOCHROMOCYTOMA; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRENATAL GROWTH; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SIDE EFFECT; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THIRD TRIMESTER PREGNANCY; UNSPECIFIED SIDE EFFECT; UREA NITROGEN BLOOD LEVEL; VAGINAL DELIVERY; ARTICLE; FEMALE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84856446187     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318249ff06     Document Type: Review

References (87)

1. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369-77. (Level III) (Pubitemid 34874806)
2. Vanek M, Sheiner E, Levy A, Mazor M. Chronic hypertension and the risk for adverse pregnancy outcome after superimposed preeclampsia. Int J Gynaecol Obstet 2004; 86:7-11. (Level II-3) (Pubitemid 38781817)
3. Lawler J, Osman M, Shelton JA, Yeh J. Population-based analysis of hypertensive disorders in pregnancy. Hypertens Pregnancy 2007;26:67-76. (Level II-3) (Pubitemid 46649348)
4. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens 2010;4:68-78. (Level III)
5. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline No. 206. Society of Obstetricians and Gynae-cologists of Canada. J Obstet Gynaecol Can 2008;30 (suppl 1):S1-S48. (Level III)
6. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Society of Obstetric Medicine of Australia and New Zealand. Aust N Z J Obstet Gynaecol 2009;49:242-6. (Level III)
7. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE Clinical Guideline 107. National Institute for Health and Clinical Excellence. London (UK): NICE; 2010. Available at: http://www.nice.org.uk/nicemedia/live/13098/50418/50418.pdf. Retrieved August 23, 2011. (Level III)
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22. (Level III)
9. Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley's hypertensive disorders in pregnancy. 3rd ed. San Diego (CA): Elsevier; 2009. (Level III)
10. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-67. (Level III)
11. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 2007;52:1046-51. (Level II-3) (Pubitemid 350305089)
12. Parrish MR, Laye MR, Wood T, Keiser SD, Owens MY, May WL, et al. Impedance cardiography facilitates differentiation of severe and superimposed preeclampsia from other hypertensive disorders. Hypertens Pregnancy 2010. DOI: 10.3109/10641955.2010.507850. (Level II-3)
13. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000;96:849-60. (Level III)
14. Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol 2007;197:273.e1-273.e7. (Level II-3)
15. Agency for Healthcare Research and Quality. Management of chronic hypertension during pregnancy. Evidence Reports/Technology Assessments No. 14. Rockville (MD): AHRQ; 2000. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK33137/. Retrieved August 23, 2011. (Level III)
16. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gyne-col Scand 2005;84:419-24. (Level II-3) (Pubitemid 40663440)
17. Vigil-De Gracia P, Lasso M, Montufar-Rueda C. Perinatal outcome in women with severe chronic hypertension during the second half of pregnancy. Int J Gynaecol Obstet 2004;85:139-44. (Level III) (Pubitemid 38510227)
18. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Chronic hypertension as a risk factor for offspring to be born small for gestational age. Acta Obstet Gynecol Scand 2006;85:1046-50. (Level II-3) (Pubitemid 44277046)
19. Allen VM, Joseph K, Murphy KE, Magee LA, Ohlsson A. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Pregnancy Childbirth 2004;4:17. (Level II-3)
20. Magee LA, von Dadelszen P, Bohun CM, Rey E, El-Zibdeh M, Stalker S, et al. Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. J Obstet Gynaecol can 2003;25:372-82. (Level II-3)
21. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008;51:1002-9. (Level II-2) (Pubitemid 351398985)
22. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women. BJOG 2008;115:1436-42. (Level II-3)
23. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996;103:123-9. (Level II-3) (Pubitemid 26054525)
24. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986;67:517-22. (Level III) (Pubitemid 16116269)
25. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994;171:410-6. (Level II-3) (Pubitemid 24279226)
26. Powrie RO. A 30-year-old woman with chronic hypertension trying to conceive. JAMA 2007;298:1548-58. (Level III) (Pubitemid 47533562)
27. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339:667-71. (Level II-2) (Pubitemid 28402091)
28. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency [published erratum appears in N Engl J Med 1997;336:739].
29. N Engl J Med 1996;335:226-32.(Level II-3)
30. Hibbard JU, Korcarz CE, Nendaz GG, Lindheimer MD, Lang RM, Shroff SG. The arterial system in pre-eclampsia and chronic hypertension with superimposed pre-eclampsia. BJOG 2005;112:897-903. (Level II-3) (Pubitemid 40896954)
31. Mabie WC, Hackman BB, Sibai BM. Pulmonary edema associated with pregnancy: echocardiographic insights and implications for treatment. Obstet Gynecol 1993;81: 227-234. (Level III) (Pubitemid 23050160)
32. Cruz MO, Briller J, Hibbard JU. Update on peripartum cardiomyopathy. Obstet Gynecol Clin North Am 2010; 37:283-303. (Level III)
33. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Hypertension 2003;42:1206-52. (Level III) (Pubitemid 37553153)
34. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960-6; discussion 966-7. (Level I)
35. Cote AM, Brown MA, Lam E, von Dadelszen P, Firoz T, Liston RM, et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hyperten-sive pregnant women: systematic review. BMJ 2008;336: 1003-6. (Level III) (Pubitemid 351656092)
36. Cote AM, Firoz T, Mattman A, Lam EM, von Dadelszen P, Magee LA. The 24-hour urine collection: gold standard or historical practice? Am J Obstet Gynecol 2008;199:625.e1-625.e6. (Level II-3)
37. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Lancet 2010;376:631-44. (Level III)
38. Cunningham FG, Cox SM, Harstad TW, Mason RA, Pritchard JA. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990;163:453-9. (Level III) (Pubitemid 20287608)
39. Botchan A, Hauser R, Kupfermine M, Grisaru D, Peyser MR, Lessing JB. Pheochromocytoma in pregnancy: case report and review of the literature. Obstet Gynecol Surv 1995;50:321-7. (Level III)
40. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeo-chromocytoma. Lancet 2005;366:665-75. (Level III)
41. Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992;79:130-7. (Level III)
42. Lindheimer, MD; Kanter, D. Interpreting abnormal proteinuria in pregnancy: The need for a more pathophysiological approach. Obstet Gynecol 2010;115(2, Part 1): 365-375.(Level III)
43. Lim KH, Friedman SA, Ecker JL, Kao L, Kilpatrick SJ. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998;178:1067-71. (Level II-3) (Pubitemid 28247188)
44. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008;199:268.e1-268. e9. (Level II-2)
45. August P, Helseth G, Cook EF, Sison C. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol 2004;191:1666-72. (Level III) (Pubitemid 39491195)
46. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first-trimester screening for early preeclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27:13-7. (Level II-3) (Pubitemid 43129084)
47. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor [published erratum appears in Am J Obstet Gyne-col 2007;196:614].
48. Am J Obstet Gynecol 2007;196:326.e1-326.13. (Level II-3)
49. Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007;197:28.e1-28.e6. (Level II-3)
50. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network. PLoS One 2010;5:e13263. (Level II-2)
51. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002252. DOI: 10.1002/14651858. CD002252.pub2. (Meta-analysis)
52. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92. (Meta-analysis) (Pubitemid 30068551)
53. Nakhai-Pour HR, Rey E, Berard A. Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension. Am J Obstet Gynecol 2009;201:180.e1-180.e8. (Level II-3)
54. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:1332-6. (Level III) (Pubitemid 29219050)
55. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002;24:941-5. (Level III)
56. Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. Centre for Maternal and Child Enquiries (CMACE). BJOG 2011;118(suppl 1):1-203 (Level II-3)
57. Valabhji J, Robinson S, Poulter C, Robinson AC, Kong C, Henzen C, et al. Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care 2000;23:539-43. (Level II-3) (Pubitemid 30185801)
58. Courreges JP, Bacha J, Aboud E, Pradier P. Prevalence of renal artery stenosis in type 2 diabetes. Diabetes Metab 2000;26(suppl 4):90-6. (Level II-3) (Pubitemid 30618362)
59. Magee L, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD002863. DOI: 10.1002/14651858.CD002863. (Meta-analysis)
60. Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7. (Level II-3) (Pubitemid 29268384)
61. Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 1999;93:725-33. (Level I) (Pubitemid 29190671)
62. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. Br J Obstet Gynaecol 1998;105:718-22. (Level I)
63. Magee LA, Miremandi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193:153-163. (Level II-3) (Pubitemid 40991839)
64. Ounsted M, Cockburn J, Moar VA, Redman CW. Maternal hypertension with superimposed pre-eclampsia: effects on child development at 71/2 years. Br J Obstet Gynaecol 1983;90:644-9. (Level II-3) (Pubitemid 13073820)
65. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993;168:152-6. (Level I) (Pubitemid 23047632)
66. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150:831-5. (Level I) (Pubitemid 15237763)
67. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J 1985;290:17-23. (Level III) (Pubitemid 15075976)
68. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:246-54. (Level III) (Pubitemid 40229437)
69. Emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Committee Opinion No. 514. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:1465-8. (Level XXX)
70. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001449. DOI: 10.1002/14651858.CD001449.pub2. (Meta-analysis)
71. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003;327: 955-60. (Meta-analysis) (Pubitemid 37330398)
72. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003514. DOI: 10.1002/14651858.CD003514.pub2. (Meta-analysis)
73. Barr M Jr, Cohen MM Jr. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991;44:485-95. (Level III)
74. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gyne-col 1991;78:128-35. (Level III)
75. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 9th ed. Philadelphia (PA): Wolters Kluwer/Lippincott Williams & Wilkins; 2011. (Level III)
76. Buttar HS. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997;176:61-71. (Level III) (Pubitemid 27491467)
77. Pryde PG, Sedman AB, Nugent CE, Barr M Jr. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993;3:1575-82. (Level III)
78. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51. (Level II-3) (Pubitemid 43855047)
79. Bos-Thompson MA, Hillaire-Buys D, Muller F, Dechaud H, Mazurier E, Boulot P, et al. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth [published erratum appears in Ann Pharmacother 2005;39:389].
80. Ann Pharmacother 2005;39:157-61. (Level III)
81. Serreau R, Luton D, Macher MA, Delezoide AL, Garel C, Jacqz-Aigrain E. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG 2005;112:710-2. (Level III) (Pubitemid 40852836)
82. Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 1996;174:812-7. (Level II-3) (Pubitemid 26111650)
83. Freeman RK. Antepartum testing in patients with hypertensive disorders in pregnancy. Semin Perinatol 2008;32:271-3. (Level III) (Pubitemid 352001330)
84. Pircon RA, Lagrew DC, Towers CV, Dorchester WL, Gocke SE, Freeman RK. Antepartum testing in the hypertensive patient: when to begin. Am J Obstet Gynecol 1991;164:1563-9; discussion 1569-70. (Level III)
85. Spong CY, Mercer BM, D'Alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm and early term birth. Obstet Gynecol 2011;118:323-33. (Level III)
86. Polley LS. Hypertensive disorders. In: Chestnut DH, Polley LS, Tsen LC, Wong CA, editors. Chestnut's obstetric anesthesia: principles and practice. 4th ed. Philadelphia (PA): Mosby Elsevier; 2009. p. 975-1007. (Level III)
87. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007; 106:843-63. (Level III)